Analyst Ratings for Sigilon Therapeutics (SGTX)

SGTX Rating Summary

  |   Expand Research on SGTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/30/2023 BTIG Thomas Shrader Downgrade Neutral
(Buy)		 N/A
(N/A)		 3.93
(22.47)		 471.76% Details
1/18/2023 Canaccord Whitney Ijem New Coverage Buy
(N/A)		 N/A
(N/A)		 0.41
(22.47)		 5380.49% Details